AAAAAA

   
Results: 1-17 |
Results: 17
SIMULTANEOUS HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OFA GLUCURONYL PRODRUG OF DOXORUBICIN, DOXORUBICIN AND ITS METABOLITES IN HUMAN LUNG-TISSUE
Authors: MURDTER TE SPERKER B BOSSLET K FRITZ P KROEMER HK
Citation: Te. Murdter et al., SIMULTANEOUS HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OFA GLUCURONYL PRODRUG OF DOXORUBICIN, DOXORUBICIN AND ITS METABOLITES IN HUMAN LUNG-TISSUE, Journal of chromatography B. Biomedical sciences and applications, 709(2), 1998, pp. 289-295
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF A VERAPAMIL PRODRUG FOR SELECTIVE MDR REVERSAL AT THE TUMOR SITE
Authors: DESBENE S MICHEL S DUFAT H TILLEQUIN F MONNERET C BOSSLET K KOCH M
Citation: S. Desbene et al., DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF A VERAPAMIL PRODRUG FOR SELECTIVE MDR REVERSAL AT THE TUMOR SITE, Annals of oncology, 9, 1998, pp. 559-559
PRODRUGS OF ANTHRACYCLINES FOR USE IN ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY
Authors: FLORENT JC DONG X GAUDEL G MITAKU S MONNERET C GESSON JP JACQUESY JC MONDON M RENOUX B ANDRIANOMENJANAHARY S MICHEL S KOCH M TILLEQUIN F GERKEN M CZECH J STRAUB R BOSSLET K
Citation: Jc. Florent et al., PRODRUGS OF ANTHRACYCLINES FOR USE IN ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY, Journal of medicinal chemistry, 41(19), 1998, pp. 3572-3581
ELUCIDATION OF THE MECHANISM ENABLING TUMOR SELECTIVE PRODRUG MONOTHERAPY
Authors: BOSSLET K STRAUB R BLUMRICH M CZECH J GERKEN M SPERKER B KROEMER HK GESSON JP KOCH M MONNERET C
Citation: K. Bosslet et al., ELUCIDATION OF THE MECHANISM ENABLING TUMOR SELECTIVE PRODRUG MONOTHERAPY, Cancer research, 58(6), 1998, pp. 1195-1201
GLUCURONIDE PRODRUGS OF HYDROXY COMPOUNDS FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - A PHENOL NITROGEN-MUSTARD CARBAMATE
Authors: SCHMIDT F FLORENT JC MONNERET C STRAUB R CZECH J GERKEN M BOSSLET K
Citation: F. Schmidt et al., GLUCURONIDE PRODRUGS OF HYDROXY COMPOUNDS FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - A PHENOL NITROGEN-MUSTARD CARBAMATE, Bioorganic & medicinal chemistry letters, 7(8), 1997, pp. 1071-1076
BIOACTIVATION OF A GLUCURONYL-SPACER-DOXORUBICIN PRODRUG BY BETA-GLUCURONIDASE - A STUDY USING THE HUMAN LUNG PERFUSION MODEL
Authors: MURDTER TE SPERKER B FRIEDEL G LINDER A KIVISTO KT MCCLELLAN M FRITZ P BOSSLET K KROEMER HK
Citation: Te. Murdter et al., BIOACTIVATION OF A GLUCURONYL-SPACER-DOXORUBICIN PRODRUG BY BETA-GLUCURONIDASE - A STUDY USING THE HUMAN LUNG PERFUSION MODEL, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 455-455
INTERINDIVIDUAL VARIABILITY IN EXPRESSION AND ACTIVITY OF HUMAN BETA-GLUCURONIDASE IN LIVER AND KIDNEY - CONSEQUENCES FOR DRUG-METABOLISM
Authors: SPERKER B MURDTER TE SCHICK M ECKHARDT K BOSSLET K KROEMER HK
Citation: B. Sperker et al., INTERINDIVIDUAL VARIABILITY IN EXPRESSION AND ACTIVITY OF HUMAN BETA-GLUCURONIDASE IN LIVER AND KIDNEY - CONSEQUENCES FOR DRUG-METABOLISM, The Journal of pharmacology and experimental therapeutics, 281(2), 1997, pp. 914-920
BIOACTIVATION OF A DOXORUBICIN GLUCURONIDE PRODRUG IN HUMAN LUNG AND BRONCHIAL-CARCINOMA - ROLE OF ELEVATED BETA-GLUCURONIDASE ACTIVITY
Authors: SPERKER B MURDTER TE FRITZ P LINDER A FRIEDEL G BOSSLET K EICHELBAUM M KROEMER HK
Citation: B. Sperker et al., BIOACTIVATION OF A DOXORUBICIN GLUCURONIDE PRODRUG IN HUMAN LUNG AND BRONCHIAL-CARCINOMA - ROLE OF ELEVATED BETA-GLUCURONIDASE ACTIVITY, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 24-24
ENHANCED UPTAKE OF DOXORUBICIN INTO BRONCHIAL-CARCINOMA - BETA-GLUCURONIDASE MEDIATES RELEASE OF DOXORUBICIN FROM A GLUCURONIDE PRODRUG (HMR-1826) AT THE TUMOR SITE
Authors: MURDTER TE SPERKER B KIVISTO KT MCCLELLAN M FRITZ P FRIEDEL G LINDER A BOSSLET K TOOMES H DIERKESMANN R KROEMER HK
Citation: Te. Murdter et al., ENHANCED UPTAKE OF DOXORUBICIN INTO BRONCHIAL-CARCINOMA - BETA-GLUCURONIDASE MEDIATES RELEASE OF DOXORUBICIN FROM A GLUCURONIDE PRODRUG (HMR-1826) AT THE TUMOR SITE, Cancer research, 57(12), 1997, pp. 2440-2445
PRODRUGS OF ANTHRACYCLINE ANTIBIOTICS SUITED FOR TUMOR-SPECIFIC ACTIVATION
Authors: AZOULAY M FLORENT JC MONNERET C GESSON JP JACQUESY JC TILLEQUIN F KOCH M BOSSLET K CZECH J HOFFMAN D
Citation: M. Azoulay et al., PRODRUGS OF ANTHRACYCLINE ANTIBIOTICS SUITED FOR TUMOR-SPECIFIC ACTIVATION, Anti-cancer drug design, 10(6), 1995, pp. 441-450
8TH INTERNATIONAL-AEK-SYMPOSIUM OF THE DIVISION OF EXPERIMENTAL CANCER-RESEARCH OF THE GERMAN-CANCER-SOCIETY - 29-31 MARCH 1995, HEIDELBERG, GERMANY
Authors: RABES HM GABBERT HE GRUNICKE H LUTZ WK BORNKAMM G BRANDNER G BOSSLET K RAJEWSKY MF EISENBRAND G SCHNEIDER MR VONHOEGEN P
Citation: Hm. Rabes et al., 8TH INTERNATIONAL-AEK-SYMPOSIUM OF THE DIVISION OF EXPERIMENTAL CANCER-RESEARCH OF THE GERMAN-CANCER-SOCIETY - 29-31 MARCH 1995, HEIDELBERG, GERMANY, Journal of cancer research and clinical oncology, 121(11), 1995, pp. 683-690
MONOCLONAL-ANTIBODY BW835 DEFINES A SITE-SPECIFIC THOMSEN-FRIEDENREICH DISACCHARIDE LINKED TO THREONINE WITHIN THE VTSA MOTIF OF MUC1 TANDEM REPEATS
Authors: HANISCH FG STADIE T BOSSLET K
Citation: Fg. Hanisch et al., MONOCLONAL-ANTIBODY BW835 DEFINES A SITE-SPECIFIC THOMSEN-FRIEDENREICH DISACCHARIDE LINKED TO THREONINE WITHIN THE VTSA MOTIF OF MUC1 TANDEM REPEATS, Cancer research, 55(18), 1995, pp. 4036-4040
PRODRUGS OF ANTHRACYCLINES FOR CHEMOTHERAPY VIA ENZYME MONOCLONAL-ANTIBODY CONJUGATES
Authors: GESSON JP JACQUESY JC MONDON M PETIT P RENOUX B ANDRIANOMENJANAHARY S VAN HDT KOCH M MICHEL S TILLEQUIN F FLORENT JC MONNERET C BOSSLET K CZECH J HOFFMANN D
Citation: Jp. Gesson et al., PRODRUGS OF ANTHRACYCLINES FOR CHEMOTHERAPY VIA ENZYME MONOCLONAL-ANTIBODY CONJUGATES, Anti-cancer drug design, 9(5), 1994, pp. 409-423
BIOCHEMICAL-PROPERTIES OF RECOMBINANT HUMAN BETA-GLUCURONIDASE SYNTHESIZED IN BABY HAMSTER-KIDNEY CELLS
Authors: GEHRMANN MC OPPER M SEDLACEK HH BOSSLET K CZECH J
Citation: Mc. Gehrmann et al., BIOCHEMICAL-PROPERTIES OF RECOMBINANT HUMAN BETA-GLUCURONIDASE SYNTHESIZED IN BABY HAMSTER-KIDNEY CELLS, Biochemical journal, 301, 1994, pp. 821-828
7TH INTERNATIONAL-SYMPOSIUM OF THE DIVISION OF EXPERIMENTAL CANCER-RESEARCH (AEK) OF THE GERMAN-CANCER-SOCIETY - 24-26 MARCH, 1993, HEIDELBERG, GERMANY
Authors: GRUNICKE H PYERIN W EISENBRAND G HAVEMANN K RABES HM MOLLING K SCHWAB M LUTZ WK WAHRENDORF J SCHIRRMACHER V BOSSLET K
Citation: H. Grunicke et al., 7TH INTERNATIONAL-SYMPOSIUM OF THE DIVISION OF EXPERIMENTAL CANCER-RESEARCH (AEK) OF THE GERMAN-CANCER-SOCIETY - 24-26 MARCH, 1993, HEIDELBERG, GERMANY, Journal of cancer research and clinical oncology, 120(3), 1994, pp. 179-185
TUMOR-SELECTIVE PRODRUG ACTIVATION BY FUSION PROTEIN-MEDIATED CATALYSIS
Authors: BOSSLET K CZECH J HOFFMANN D
Citation: K. Bosslet et al., TUMOR-SELECTIVE PRODRUG ACTIVATION BY FUSION PROTEIN-MEDIATED CATALYSIS, Cancer research, 54(8), 1994, pp. 2151-2159
MONOCLONAL-ANTIBODY-BW494 DEFINES A BLOOD-GROUP LEWIS(A) TYPE-1 CHAIN-RELATED ANTIGEN ON CARCINOMA-ASSOCIATED MUCINS/
Authors: HANISCH FG AUERBACH B BOSSLET K KOLBE K KARSTEN U NAKAHARA Y OGAWA T UHLENBRUCK G
Citation: Fg. Hanisch et al., MONOCLONAL-ANTIBODY-BW494 DEFINES A BLOOD-GROUP LEWIS(A) TYPE-1 CHAIN-RELATED ANTIGEN ON CARCINOMA-ASSOCIATED MUCINS/, Biological chemistry Hoppe-Seyler, 374(12), 1993, pp. 1083-1091
Risultati: 1-17 |